- The collaboration is based on earlier studies conducted with the U.S. Naval Medical Center program.
- The total economic impact of PTSD in the U.S. is estimated at $232.2 billion.
- Firefly’s system provides objective neurological data to guide accurate diagnoses and customised treatment plans.
Firefly Neuroscience Inc. (AIFF) announced on Thursday an agreement with the Department of War to deploy its artificial intelligence-driven EEG/ERP platform for evaluating and treating active-duty personnel and veterans affected by PTSD and traumatic brain injuries.
The initiative focuses on using advanced brain-monitoring technology to address persistent challenges tied to military health.
Following the update, Firefly Neuroscience stock traded over 33% on Thursday morning. On Stocktwits, retail sentiment around the stock changed to ‘neutral’ from ‘bearish’ territory the previous day amid ‘normal’ message volume levels.
Partnership With Defense Sector
The effort builds on earlier research conducted with a U.S. Naval Medical Center program, laying the groundwork for broader adoption across military healthcare systems.
Post-traumatic stress disorder and traumatic brain injuries remain among the most pressing issues facing the armed forces. The overall additional economic impact of PTSD in the U.S. is estimated at $232.2 billion, with roughly $42.7 billion linked specifically to service members and veterans.
Technology And Clinical Application
Firefly’s platform, which has received clearance from the U.S. Food and Drug Administration (FDA), uses AI to analyze brainwave activity and deliver objective neurological insights. The system aims to assist clinicians in making more accurate diagnoses, tailoring treatment strategies, and tracking patient progress over time.
“We believe that this ongoing strategic partnership positions us well to benefit from the significant and growing U.S. government investment in military brain health — with a validated, FDA-cleared platform.”
-Greg Lipschitz, CEO, Firefly
AIFF stock has gained over 90% year to date.
Also See: NAVN Stock Draws Cheer After Strong Q4 – BMO Sees 76% Upside To Share Price, Dismisses AI Concerns
For updates and corrections, email newsroom[at]stocktwits[dot]com.